HRMY•benzinga•
Harmony Biosciences Receives Refusal To File Letter From FDA For Pitolisant; Says 2025 Net Revenue Guidance Remains Unchanged At $820M-$860M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 19, 2025 by benzinga